MYL-1701P

· Mylan Pharmaceuticals Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MYL-1701P, covering 2023-03-07 to 2026-08-03. Get the full timeline:

Most recent: Clinical Trial Results: Extension Study of MYL-1701P-3001 for Safety and Efficacy [Phase 3]